Innovo Research to Begin Clinical Trials Through Nationwide Network

New group to focus efforts on greater patient access to trial sponsors to bring new therapies to market more safely and sooner.

Innovo Research (www.innovoresearch.com), a new venture created by Wilmington Health (Wilmington, North Carolina) and Christie Clinic (Champaign, Illinois), and in partnership with QuintilesIMS, has launched to advance medical research across the country. Now pharmaceutical companies around the world can work with high-performing Accountable Care Organizations (ACOs) that can use their individual electronic medical records to more efficiently bring therapeutic studies to completion.

“It is very exciting to bring Innovo Research to life,” said Jeff James, Wilmington Health Chief Executive Officer. “Through our association with Christie Clinic and the new relationships we are building across the country with extraordinary provider groups, Innovo Research will be able to provide a geographically and demographically diverse population to drug companies as they evaluate the efficacy of new therapies.”

Innovo Research has teamed up with QuintilesIMS, a recognized leader in healthcare intelligence, to provide on-site management for each sponsored study that engages the Innovo Research network. QuintilesIMS will ensure each piece of data is collected consistently to provide a reliable conclusion to study sponsors.

“Having a partner like QuintilesIMS was critical as we began this journey to providing greater value to the clinical trial system for our study sponsors,” stated Kenny Bilger, Christie Clinic Chief Executive Officer. “With Innovo Research’s ability to access patients and the data confidence that QuintilesIMS provides, we give the pharmaceutical industry the best of both worlds.”

Accessing and analyzing patient data to identify potential participants is at the core of Innovo Research’s capabilities. Utilizing aggregated electronic medical records from participating ACOs, like Wilmington Health and Christie Clinic, Innovo Research can quickly provide detailed accounting of patient populations that fit health status, demographic, and/or geographic parameters for study participants.

“Harnessing the power of the electronic health record is a core competency for both Wilmington Health and Christie Clinic as we have regularly engaged in clinical trials,” stated James. “By combining our efforts, and bringing new ACOs into our network, we can ensure many study sponsors access to the patients that they need to collect this valuable data. In addition, we will be able to identify quickly any gaps in care across the entire network and find the types of studies that would most benefit our patient population. It is truly a win-win-win situation.”

Since Innovo Research is founded by two medical groups, continued emphasis will be placed on the “triple aim” of health care today: 1) improving healthcare outcomes for patients, 2) reducing the cost of healthcare to patients and across the system, 3) improving patient engagement and satisfaction with their healthcare experience.

“The more actively engaged patient is one that tends to have better outcomes from the therapies introduced to them by their healthcare provider and in the long term show overall lower cost of care,” said Bilger. “Clinical trials are one of many ways to better engage patients in their healthcare, which provides two benefits. First, the patients that participate tend to be more involved in their healthcare, so their health often improves regardless of the impact of therapy being tested. Secondly, more engaged patients provide an excellent feedback during a trial; information that can be used to benefit the entire population.”

ABOUT WILMINGTON HEALTH – With a focus on quality, Wilmington Health is leading the way in providing excellent healthcare, reducing costs, and improving the patient experience. Wilmington Health has provided premier healthcare to the residents of Southeastern North Carolina for over 40 years. It is the largest private, fully integrated, multi-specialty medical group practice in the area with over 20 locations (including Convenient Care and Urgent Care). For more information about Wilmington Health, please call 910.341.3300, or visit www.wilmingtonhealth.com.

ABOUT CHRISTIE CLINIC – Christie Clinic has been serving the community since 1929 as the oldest multi-specialty medical practice in central Illinois. Today, we have more than 185 medical providers covering 40 specialties in 22-plus locations. Our team can also be found sponsoring and volunteering at community-wide health and education events including the annual Christie Clinic Illinois Marathon held each spring in Champaign.  For more information about Christie Clinic and list of locations, specialties, and providers, please visit www.christieclinic.com.

ABOUT QUINTILESIMS – QuintilesIMS (NYSE:Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles Transnational and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial, bringing customers a unique opportunity to realize the full potential of innovations and advanced healthcare outcomes.

CONTACT

Jeff James
910.815.6103
jjames@wilmingtonhealth.com

###

Source: Innovo Research


Categories: Healthcare, Pharmaceuticals and Biotech, Healthcare and Medical Informatics

Tags: Accountable Care Organizations, Christie Clinic, clinical, Innovo, Innovo Research, new venture, pharmaceutical, trials, Wilmington Health